Null effect of circulating sphingomyelins on risk for breast cancer: a Mendelian randomization report using Breast Cancer Association Consortium (BCAC) data
View ORCID ProfileCharleen D. Adams
doi: https://doi.org/10.1101/19013540
Charleen D. Adams
Beckman Research Institute
Data Availability
Data are publicly available via MR-Base and BCAC.
Posted December 04, 2019.
Null effect of circulating sphingomyelins on risk for breast cancer: a Mendelian randomization report using Breast Cancer Association Consortium (BCAC) data
Charleen D. Adams
medRxiv 19013540; doi: https://doi.org/10.1101/19013540
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (715)
- Anesthesia (209)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12870)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4665)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2968)
- Health Policy (1079)
- Hematology (394)
- HIV/AIDS (940)
- Medical Education (432)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4449)
- Nursing (239)
- Nutrition (653)
- Oncology (2314)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (329)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (505)
- Pediatrics (1207)
- Primary Care Research (506)
- Public and Global Health (7047)
- Radiology and Imaging (1563)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)